Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) reached a new 52-week high during trading on Tuesday . The stock traded as high as $9.55 and last traded at $9.43, with a volume of 19301 shares traded. The stock had previously closed at $9.35.
Fresenius SE & Co. KGaA Stock Up 0.5 %
The company’s fifty day moving average is $8.64 and its 200-day moving average is $7.81.
Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.22 EPS for the quarter. The firm had revenue of $5.83 billion for the quarter. As a group, analysts predict that Fresenius SE & Co. KGaA will post 0.82 earnings per share for the current fiscal year.
Fresenius SE & Co. KGaA Company Profile
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Read More
- Five stocks we like better than Fresenius SE & Co. KGaA
- Insider Buying Explained: What Investors Need to Know
- Matador Resources Insiders Keep Buying Its Stock, Should You?
- Why Invest in 5G? How to Invest in 5G Stocks
- Oracle Can Turn the Magnificent 7 Into 8: Here’s Why
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Palantir Stock Is Up 14% on S&P 500 News: Is It Time to Buy?
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.